WBWA
AVNS icon

William B. Walkup & Associates’s Avanos Medical AVNS Stock Holding History

William B. Walkup & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330 Hold
23
– – ﹤0.01% 161
2025
Q4 		$258 Hold
23
– – ﹤0.01% 166
2025
Q3 		$266 Hold
23
– – ﹤0.01% 162
2025
Q2 		$282 Hold
23
– – ﹤0.01% 160
2025
Q1 		$330 Hold
23
– – ﹤0.01% 160
2024
Q4 		$366 Hold
23
– – ﹤0.01% 158
2024
Q3 		$552 Hold
23
– – ﹤0.01% 155
2024
Q2 		$458 Buy
+23
New +$448 ﹤0.01% 155

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

William B. Walkup & Associates's AVNS Position: Q1 2026 in Review

William B. Walkup & Associates held its Avanos Medical (AVNS) position steady in Q1 2026 at 23 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #161.

William B. Walkup & Associates first reported a position in AVNS in Q2 2024 and has held it in 8 quarters since. The position peaked at $552 in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • William B. Walkup & Associates held 23 shares of Avanos Medical worth $330 as of Q1 2026.
  • William B. Walkup & Associates left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of William B. Walkup & Associates's portfolio in Q1 2026, its #161 holding.
  • William B. Walkup & Associates first reported a position in Avanos Medical in Q2 2024 and has held it in 8 quarters since.
  • William B. Walkup & Associates's Avanos Medical position peaked at $552 in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on William B. Walkup & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.